Fibrinolysis in Intermediate-Risk PE Between Prevention and Risk – Unidad de ETV Hospital Gregorio Marañón
Unidad de ETV Hospital Gregorio Marañón shared a post on X about a recent article by Eva Cervilla-Muñoz et al., published in Journal of Clinical Medicine:
“The use of systemic fibrinolysis in intermediate-risk PE remains one of the great clinical debates: Prevent hemodynamic deterioration or assume greater hemorrhagic risk?
In our new article, conducted together with CardioHGUGM, we analyze a real-world cohort.”
Title: Systemic Fibrinolysis in Symptomatic Intermediate-Risk Pulmonary Embolism: A Real-World Cohort Study
Authors: Eva Cervilla-Muñoz, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, Miriam Juárez-Fernández, Iago Sousa-Casasnovas, Lucía Ordieres-Ortega, Marina López-Rubio, Luis-Antonio Alvarez-Sala Walther, Francisco Galeano-Valle
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 29, 2026, 14:32Ella Sophia Ellis: Launching the ITP Young Adults Group to Build Connection and Support
-
Apr 29, 2026, 14:25Florian Fleckenstein: Transarterial Embolization in Symptomatic Hip Osteoarthritis
-
Apr 29, 2026, 14:22Marilena Vrana: Advancing Early Diagnosis and Access to Plasma Medicines for World PI Week 2026
-
Apr 29, 2026, 14:20Gerrit M. Grosse: A Special Issue in Acta Neurologica Scandinavica Wiley Calls for Your Research
-
Apr 29, 2026, 14:08Shivam Gupta: Heat Stroke Awareness Program by SGB by BrandSafway Calls for Hydration and Rapid Response
-
Apr 29, 2026, 14:07Manmit Kaur: Advancing Practice and Reaching New Personal Goals in One Week
-
Apr 29, 2026, 14:03Blood Clots Can Happen to Anyone – NBCA
-
Apr 29, 2026, 14:03Tushar Pandey: The Spectrum of Bleeding Disorders
-
Apr 29, 2026, 14:03Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention